Publikationen (136) Publikationen von María del Carmen Berasain Lasarte

filter_list

2025

  1. Expression landscape of epigenetic genes in human hepatocellular carcinoma

    Journal of Physiology and Biochemistry, Vol. 81, Núm. 3, pp. 699-727

  2. FGF21 and APOA1 mRNA-based therapies for the treatment of experimental acute pancreatitis

    Journal of Translational Medicine, Vol. 23, Núm. 1

  3. Gut-to-Bile transfer of microbially amidated minor bile acids in patients with hepatopancreatobiliary disorders

    Hepatology

  4. Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study

    Liver International, Vol. 45, Núm. 4

  5. New Insights and Open Questions on the Molecular and Cellular Crosstalk Governing Hepatocyte Proliferation

    Cellular and Molecular Gastroenterology and Hepatology

  6. Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma

    Journal of experimental & clinical cancer research : CR, Vol. 44, Núm. 1, pp. 13

  7. The Search for Risk, Diagnostic, and Prognostic Biomarkers of Cholangiocarcinoma and Their Biological and Clinicopathologic Significance

    American Journal of Pathology, Vol. 195, Núm. 3, pp. 422-436

2024

  1. Caspases compromise SLU7 and UPF1 stability and NMD activity during hepatocarcinogenesis

    JHEP Reports, Vol. 6, Núm. 8

  2. Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression

    Journal of Physiology and Biochemistry, Vol. 80, Núm. 4, pp. 865-879

  3. Identification of PRMT5 as a therapeutic target in cholangiocarcinoma

    Gut, Vol. 74, Núm. 1, pp. 116-127

  4. Mouse models of primary sclerosing cholangitis: we just can’t get enough

    Metabolism and Target Organ Damage

  5. New insights into the regulation of bile acids synthesis during the early stages of liver regeneration: A human and experimental study

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 5

  6. Non-mitogenic FGF19 mRNA-based therapy for the treatment of experimental metabolic dysfunction-associated steatotic liver disease (MASLD)

    Clinical science (London, England : 1979), Vol. 138, Núm. 20, pp. 1265-1284

  7. Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment

    Clinical and Molecular Hepatology, Vol. 30, Núm. 2, pp. 177-190

  8. When you eat and when you sleep matters: Circadian dysfunction revealed as a direct hepatic carcinogen in a humanized mouse model

    Journal of Hepatology

2023

  1. Author Correction: Defective HNF4alpha-dependent gene expression as a driver of hepatocellular failure in alcoholic hepatitis (Nature Communications, (2019), 10, 1, (3126), 10.1038/s41467-019-11004-3)

    Nature Communications

  2. Comprehensive analysis of epigenetic and epitranscriptomic genes’ expression in human NAFLD

    Journal of Physiology and Biochemistry, Vol. 79, Núm. 4, pp. 901-924

  3. Identification and experimental validation of druggable epigenetic targets in hepatoblastoma

    Journal of Hepatology, Vol. 79, Núm. 4, pp. 989-1005

  4. Loss of liver function in chronic liver disease: An identity crisis

    Journal of Hepatology, Vol. 78, Núm. 2, pp. 401-414

  5. Mapping early serum proteome signatures of liver regeneration in living donor liver transplant cases

    BioFactors, Vol. 49, Núm. 4, pp. 912-927